arginyl-glycyl-aspartic acid and Coronary Restenosis

arginyl-glycyl-aspartic acid has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Khachigian, LM; Li, Y; McRobb, LS	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Coronary Restenosis

Article	Year
Inhibition of intimal thickening after vascular injury with a cocktail of vascular endothelial growth factor and cyclic Arg-Gly-Asp peptide. International journal of cardiology, 2016, Oct-01, Volume: 220 Topics: Animals; Carotid Arteries; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Drug Therapy, Combination; Muscle, Smooth, Vascular; Neointima; Oligopeptides; Rats; Tunica Intima; Vascular Endothelial Growth Factor A	2016

Article

Year

Inhibition of intimal thickening after vascular injury with a cocktail of vascular endothelial growth factor and cyclic Arg-Gly-Asp peptide.

International journal of cardiology, 2016, Oct-01, Volume: 220

Topics: Animals; Carotid Arteries; Cell Proliferation; Cells, Cultured; Coronary Restenosis; Drug Therapy, Combination; Muscle, Smooth, Vascular; Neointima; Oligopeptides; Rats; Tunica Intima; Vascular Endothelial Growth Factor A

2016